The global angiography devices market is witnessing strong growth as healthcare systems worldwide increasingly focus on early diagnosis, precision imaging, and minimally invasive treatment procedures. Valued at US$ 12.4 billion in 2022, the market is projected to expand at a CAGR of 6.7% from 2023 to 2031, reaching more than US$ 22.0 billion by the end of the forecast period.

Angiography plays a critical role in modern healthcare by enabling physicians to visualize blood vessels and diagnose vascular abnormalities. The technology is widely used in the detection and treatment of cardiovascular diseases, stroke, aneurysms, peripheral artery disease, and pulmonary embolism. Growing healthcare investments, technological advancements, and increasing demand for minimally invasive procedures continue to drive market expansion globally.

Growing Cardiovascular Disease Prevalence Fuels Market Demand

One of the primary drivers of the angiography devices market is the increasing prevalence of cardiovascular diseases (CVDs) worldwide. According to global health estimates, cardiovascular disorders remain among the leading causes of mortality, accounting for millions of deaths annually. The rising incidence of coronary artery disease, stroke, and peripheral vascular disorders has significantly increased the demand for advanced diagnostic imaging technologies.

Angiography devices enable healthcare professionals to identify blockages, narrowing of arteries, and other vascular abnormalities with high precision. These systems are also essential during interventional procedures such as angioplasty, stenting, thrombectomy, and embolization. As healthcare providers focus on early disease detection and preventive care, the adoption of angiography equipment is expected to accelerate further.

The aging population across developed and emerging economies is another factor contributing to market growth. Older individuals are more susceptible to cardiovascular disorders, increasing the need for diagnostic and therapeutic angiographic procedures.

Technological Advancements Revolutionizing Angiography Systems

Rapid advancements in imaging technologies are transforming the angiography devices industry. Modern digital imaging systems provide superior image quality, faster acquisition times, and improved procedural accuracy compared to conventional systems. These innovations help physicians make faster and more accurate clinical decisions while enhancing patient outcomes.

Manufacturers are increasingly introducing advanced imaging platforms equipped with artificial intelligence (AI) and machine learning capabilities. These smart systems assist clinicians in image interpretation, lesion detection, workflow optimization, and treatment planning. AI-driven angiography solutions also reduce procedural time and improve diagnostic confidence.

Another notable trend is the development of hybrid imaging systems that combine angiography with modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). These integrated platforms offer comprehensive visualization of vascular structures and surrounding tissues, enhancing diagnostic accuracy and procedural efficiency.

Cone-beam computed tomography (CBCT) technology is also gaining popularity in interventional radiology and cardiology applications. CBCT provides high-resolution three-dimensional imaging, enabling more precise navigation during complex vascular procedures.

Angiography Systems Segment Maintains Market Leadership

Based on product type, the angiography systems segment continues to dominate the global market. Continuous innovation in imaging technologies and increasing clinical demand for advanced diagnostic equipment are supporting segment growth.

X-ray angiography systems remain the most widely adopted devices due to their affordability, accessibility, and effectiveness in cardiovascular interventions. These systems are routinely used in catheterization laboratories and surgical centers for coronary angiography and stenting procedures.

CT angiography systems are also experiencing strong demand owing to their ability to generate detailed three-dimensional images of blood vessels. These systems provide excellent spatial resolution and are increasingly used for diagnosing cardiovascular and neurological conditions.

Meanwhile, MR angiography systems offer a radiation-free imaging alternative, making them suitable for patients who require repeated examinations or cannot undergo X-ray-based procedures. Additional imaging technologies such as ultrasound angiography and optical coherence tomography (OCT) are further expanding the capabilities of vascular imaging.

Coronary Angiography Continues to Lead Procedure Volumes

Among various angiography types, coronary angiography accounted for the largest market share in 2022 and is expected to maintain its dominance throughout the forecast period.

The growing burden of coronary artery disease has increased the need for accurate diagnostic procedures that can identify arterial blockages and assess blood flow within the heart. Coronary angiography remains the gold standard for evaluating coronary artery conditions and guiding treatment decisions.

Advanced coronary imaging techniques such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), and fractional flow reserve (FFR) are becoming increasingly common. These technologies provide detailed insights into arterial structure and function, helping physicians optimize patient treatment strategies and improve clinical outcomes.

Hospitals and Surgical Centers Drive Equipment Adoption

Hospitals and surgical centers represent the largest end-user segment in the angiography devices market. These facilities possess the infrastructure, specialized personnel, and financial resources required to invest in advanced imaging technologies.

Growing volumes of cardiovascular interventions and minimally invasive procedures have encouraged hospitals to upgrade existing imaging equipment and establish dedicated catheterization laboratories. Specialty surgical centers focusing on cardiovascular and neurological treatments are also increasing their adoption of angiography systems to enhance patient care and procedural efficiency.

Furthermore, rising healthcare expenditure and improved access to advanced medical technologies are supporting equipment installations across healthcare facilities worldwide.

North America Remains the Leading Regional Market

North America held the largest share of the global angiography devices market in 2022. The region benefits from a highly developed healthcare infrastructure, strong presence of leading medical device manufacturers, and widespread adoption of advanced imaging technologies.

The United States remains the largest contributor to regional revenue due to high cardiovascular disease prevalence, favorable reimbursement policies, and continuous investments in healthcare innovation. Canada is also witnessing growing demand for minimally invasive diagnostic and therapeutic procedures, contributing to regional market growth.

Meanwhile, Asia Pacific is expected to emerge as one of the fastest-growing markets during the forecast period. Rising healthcare expenditure, expanding hospital infrastructure, increasing awareness of cardiovascular health, and growing patient populations in countries such as China and India are creating significant growth opportunities.

Competitive Landscape and Future Outlook

The angiography devices market remains highly competitive, with major players focusing on product innovation, strategic collaborations, and mergers and acquisitions to strengthen their market positions. Leading companies include Abbott Laboratories, Angiodynamics, Boston Scientific Corporation, B. Braun Melsungen AG, General Electric Company, Koninklijke Philips N.V., Medtronic, Merit Medical Systems, Siemens Healthcare GmbH, Shimadzu Corporation, Canon Medical Systems Corporation, Cordis Corporation, and Toshiba Medical System Corporation.

Recent product launches and partnerships highlight the industry's commitment to advancing image-guided therapies and cardiovascular care. As AI integration, hybrid imaging technologies, and minimally invasive procedures continue to evolve, the global angiography devices market is expected to experience sustained growth through 2031, offering enhanced diagnostic precision and improved patient outcomes worldwide.